Abstract
This is the second of three papers that review international policies to control spending on drugs and to improve the efficiency of drug use. This paper reviews policies influencing doctors' prescribing of drugs--particularly the use of budgetary restrictions, information and feedback, and guidelines--and evaluates the impact of these policies. Studies evaluating incentive systems are limited, but evidence suggests that providing information on its own will not lead to substantial changes in practice and that more active strategies should be evaluated.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bradlow J., Coulter A. Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs. BMJ. 1993 Nov 6;307(6913):1186–1189. doi: 10.1136/bmj.307.6913.1186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Diekema D. J., Ferguson K. J., Doebbeling B. N. Motivation for hepatitis B vaccine acceptance among medical and physician assistant students. J Gen Intern Med. 1995 Jan;10(1):1–6. doi: 10.1007/BF02599567. [DOI] [PubMed] [Google Scholar]
- Dunne F. J. Subcortical dementia. BMJ. 1993 Jul 3;307(6895):1–2. doi: 10.1136/bmj.307.6895.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maling T. J. The New Zealand preferred medicines concept: a national scheme for audit and quality assurance of prescribing. Pharmacoeconomics. 1994 Jul;6(1):5–14. doi: 10.2165/00019053-199406010-00002. [DOI] [PubMed] [Google Scholar]
- Maynard A., Bloor K. Introducing a market to the United Kingdom's National Health Service. N Engl J Med. 1996 Feb 29;334(9):604–608. doi: 10.1056/NEJM199602293340918. [DOI] [PubMed] [Google Scholar]
- Pelc A., Castan J. P. New developments in pricing and drug reimbursement in France. Pharmacoeconomics. 1994;6 (Suppl 1):28–35. doi: 10.2165/00019053-199400061-00009. [DOI] [PubMed] [Google Scholar]
- Soumerai S. B., Avorn J., Gortmaker S., Hawley S. Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene. Am J Public Health. 1987 Dec;77(12):1518–1523. doi: 10.2105/ajph.77.12.1518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Soumerai S. B., Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. JAMA. 1990 Jan 26;263(4):549–556. [PubMed] [Google Scholar]
- Stewart-Brown S., Surender R., Bradlow J., Coulter A., Doll H. The effects of fundholding in general practice on prescribing habits three years after introduction of the scheme. BMJ. 1995 Dec 9;311(7019):1543–1547. doi: 10.1136/bmj.311.7019.1543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- vd Schulenburg J. M. The German health care system at the crossroads. Health Econ. 1994 Sep-Oct;3(5):301–303. doi: 10.1002/hec.4730030503. [DOI] [PubMed] [Google Scholar]